Jean-pierre Bizzari - Net Worth and Insider Trading
Jean-pierre Bizzari Net Worth
The estimated net worth of Jean-pierre Bizzari is at least $2 Million dollars as of 2024-05-16. Jean-pierre Bizzari is the Director of Halozyme Therapeutics Inc and owns about 52,544 shares of Halozyme Therapeutics Inc (HALO) stock worth over $2 Million. Details can be seen in Jean-pierre Bizzari's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jean-pierre Bizzari has not made any transactions after 2021-08-25 and currently still holds the listed stock(s).
Transaction Summary of Jean-pierre Bizzari
Jean-pierre Bizzari Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jean-pierre Bizzari owns 4 companies in total, including Halozyme Therapeutics Inc (HALO) , Pieris Pharmaceuticals Inc (PIRS) , and Celator Pharmaceuticals Inc (CPXX) among others .
Click here to see the complete history of Jean-pierre Bizzari’s form 4 insider trades.
Insider Ownership Summary of Jean-pierre Bizzari
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HALO | Halozyme Therapeutics Inc | 2021-08-25 | director |
PIRS | Pieris Pharmaceuticals Inc | 2016-02-16 | director |
CPXX | Celator Pharmaceuticals Inc | 2016-07-12 | director |
2023-08-23 | director |
Jean-pierre Bizzari Latest Holdings Summary
Jean-pierre Bizzari currently owns a total of 1 stock. Jean-pierre Bizzari owns 52,544 shares of Halozyme Therapeutics Inc (HALO) as of August 25, 2021, with a value of $2 Million.
Latest Holdings of Jean-pierre Bizzari
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HALO | Halozyme Therapeutics Inc | 2021-08-25 | 52,544 | 45.82 | 2,407,566 |
Holding Weightings of Jean-pierre Bizzari
Jean-pierre Bizzari Form 4 Trading Tracker
According to the SEC Form 4 filings, Jean-pierre Bizzari has made a total of 1 transactions in Halozyme Therapeutics Inc (HALO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Halozyme Therapeutics Inc is the sale of 35,000 shares on August 25, 2021, which brought Jean-pierre Bizzari around $1 Million.
Insider Trading History of Jean-pierre Bizzari
- 1
Jean-pierre Bizzari Trading Performance
Jean-pierre Bizzari Ownership Network
Ownership Network List of Jean-pierre Bizzari
Ownership Network Relation of Jean-pierre Bizzari
Jean-pierre Bizzari Owned Company Details
What does Halozyme Therapeutics Inc do?
Who are the key executives at Halozyme Therapeutics Inc?
Jean-pierre Bizzari is the director of Halozyme Therapeutics Inc. Other key executives at Halozyme Therapeutics Inc include SVP & Chief Technical Officer Michael J. Labarre , director & President and CEO Helen Torley , and SVP & Chief Financial Officer Nicole Labrosse .
Halozyme Therapeutics Inc (HALO) Insider Trades Summary
Over the past 18 months, Jean-pierre Bizzari made no insider transaction in Halozyme Therapeutics Inc (HALO). Other recent insider transactions involving Halozyme Therapeutics Inc (HALO) include a net sale of 225,862 shares made by Michael J. Labarre , a net sale of 251,061 shares made by Helen Torley , and a net sale of 30,000 shares made by Matthew L. Posard .
In summary, during the past 3 months, insiders sold 60,000 shares of Halozyme Therapeutics Inc (HALO) in total and bought 0 shares, with a net sale of 60,000 shares. During the past 18 months, 549,448 shares of Halozyme Therapeutics Inc (HALO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 549,448 shares.
Halozyme Therapeutics Inc (HALO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Halozyme Therapeutics Inc Insider Transactions
Jean-pierre Bizzari Mailing Address
Above is the net worth, insider trading, and ownership report for Jean-pierre Bizzari. You might contact Jean-pierre Bizzari via mailing address: 235 Laurel Ln, Haverfold Pa 19041.